Henlius Biotech IPO Raises Below-Target $410m
Executive Summary
Shares of China’s Shanghai Henlius Biotech will debut on the Hong Kong stock exchange later this week after the company collected $410m in an IPO that was priced at the bottom end of the targeted range.